[GAMUDA] YoY Cumulative Quarter Result on 30-Apr-2013 [#3]

Stock
[GAMUDA] GAMUDA BHD
Announcement Date
27-Jun-2013
Admission Sponsor
-
Sponsor
-
Financial Year
31-Jul-2013
Quarter
30-Apr-2013 [#3]
Profit Trend
QoQ- 23.61%
YoY- -8.13%
Quarter Report
Latest QR
Upcoming QR
GAMUDA's Result
GAMUDA's Financial Summary
View:
Show?
Cumulative Result
30/04/16 30/04/15 30/04/14 30/04/13 30/04/12 30/04/11 30/04/10 CAGR
Revenue 1,507,513 1,776,649 1,637,576 1,594,501 2,117,185 1,862,598 1,740,364 -2.36%
PBT 570,530 667,669 615,882 460,802 551,472 393,397 297,068 11.47%
Tax -62,504 -97,203 -93,407 -79,946 -126,176 -86,845 -52,782 2.85%
NP 508,026 570,466 522,475 380,856 425,296 306,552 244,286 12.96%
-
NP to SH 474,035 528,460 513,513 373,722 406,805 299,190 236,190 12.29%
-
Tax Rate 10.96% 14.56% 15.17% 17.35% 22.88% 22.08% 17.77% -
Total Cost 999,487 1,206,183 1,115,101 1,213,645 1,691,889 1,556,046 1,496,078 -6.49%
-
Net Worth 6,668,750 6,038,205 5,320,902 4,357,296 3,972,866 3,624,683 2,016,620 22.03%
Dividend
30/04/16 30/04/15 30/04/14 30/04/13 30/04/12 30/04/11 30/04/10 CAGR
Div 288,898 280,846 275,219 251,382 248,304 245,741 241,994 2.99%
Div Payout % 60.94% 53.14% 53.60% 67.26% 61.04% 82.14% 102.46% -
Equity
30/04/16 30/04/15 30/04/14 30/04/13 30/04/12 30/04/11 30/04/10 CAGR
Net Worth 6,668,750 6,038,205 5,320,902 4,357,296 3,972,866 3,624,683 2,016,620 22.03%
NOSH 2,407,491 2,340,389 2,293,492 2,094,854 2,069,201 2,047,843 2,016,620 2.99%
Ratio Analysis
30/04/16 30/04/15 30/04/14 30/04/13 30/04/12 30/04/11 30/04/10 CAGR
NP Margin 33.70% 32.11% 31.91% 23.89% 20.09% 16.46% 14.04% -
ROE 7.11% 8.75% 9.65% 8.58% 10.24% 8.25% 11.71% -
Per Share
30/04/16 30/04/15 30/04/14 30/04/13 30/04/12 30/04/11 30/04/10 CAGR
RPS 62.62 75.91 71.40 76.12 102.32 90.95 86.30 -5.20%
EPS 19.69 22.58 22.39 17.84 19.66 14.61 11.71 9.03%
DPS 12.00 12.00 12.00 12.00 12.00 12.00 12.00 0.00%
NAPS 2.77 2.58 2.32 2.08 1.92 1.77 1.00 18.48%
Adjusted Per Share Value based on latest NOSH - 2,118,516
30/04/16 30/04/15 30/04/14 30/04/13 30/04/12 30/04/11 30/04/10 CAGR
RPS 53.01 62.47 57.58 56.07 74.45 65.49 61.20 -2.36%
EPS 16.67 18.58 18.06 13.14 14.30 10.52 8.31 12.29%
DPS 10.16 9.88 9.68 8.84 8.73 8.64 8.51 2.99%
NAPS 2.3449 2.1232 1.871 1.5322 1.397 1.2745 0.7091 22.03%
Price Multiplier on Financial Quarter End Date
30/04/16 30/04/15 30/04/14 30/04/13 30/04/12 30/04/11 30/04/10 CAGR
Date 29/04/16 30/04/15 30/04/14 30/04/13 30/04/12 29/04/11 30/04/10 -
Price 4.75 5.23 4.61 4.07 3.56 3.74 3.00 -
P/RPS 7.59 6.89 6.46 5.35 3.48 4.11 3.48 13.86%
P/EPS 24.12 23.16 20.59 22.81 18.11 25.60 25.61 -0.99%
EY 4.15 4.32 4.86 4.38 5.52 3.91 3.90 1.03%
DY 2.53 2.29 2.60 2.95 3.37 3.21 4.00 -7.34%
P/NAPS 1.71 2.03 1.99 1.96 1.85 2.11 3.00 -8.93%
Price Multiplier on Announcement Date
30/04/16 30/04/15 30/04/14 30/04/13 30/04/12 30/04/11 30/04/10 CAGR
Date 29/06/16 23/06/15 26/06/14 27/06/13 28/06/12 23/06/11 24/06/10 -
Price 4.81 4.94 4.72 4.56 3.46 3.75 3.21 -
P/RPS 7.68 6.51 6.61 5.99 3.38 4.12 3.72 12.82%
P/EPS 24.43 21.88 21.08 25.56 17.60 25.67 27.41 -1.89%
EY 4.09 4.57 4.74 3.91 5.68 3.90 3.65 1.91%
DY 2.49 2.43 2.54 2.63 3.47 3.20 3.74 -6.54%
P/NAPS 1.74 1.91 2.03 2.19 1.80 2.12 3.21 -9.69%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment